Video Highlights

• Early, localized treatment of uveal melanoma is essential, as untreated intraocular tumors can metastasize and lead to systemic disease.
  Intervention aims to prevent hematogenous spread while disease remains confined to the eye.
• Plaque brachytherapy remains the standard treatment, delivering highly localized radiation via a surgically placed gold-backed applicator, enabling tumor control while minimizing collateral damage to surrounding ocular structures.
• Patient-specific plaque design, guided by tumor geometry, optimizes therapeutic dose distribution and has been associated (in this program) with a reported 0% local recurrence rate over four years.
• Integration of fine needle aspiration biopsy with gene expression profiling allows for risk stratification (low/intermediate/high), informing surveillance intervals and advancing personalized, genomics-driven management strategies.

Our ocular specialists can treat the most severe form of eye cancer, using customized ocular discs. As one of only a few hospitals performing this advanced procedure, we successfully target and destroy eye tumors while preserving a patient’s vision — with virtually no chance of recurrence.